Jane Street
VYGR icon

Jane Street’s Voyager Therapeutics VYGR Stock Holding History

Jane Street’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,300
Closed -$198K – 10261
2024
Q1 		$198K Buy
+21,300
New +$180K ﹤0.01% 8190
2022
Q3 		– Sell
-10,600
Closed -$63K – 10559
2022
Q2 		$63K Sell
10,600
-25,600
-71% -$173K ﹤0.01% 8850
2022
Q1 		$276K Buy
+36,200
New +$161K ﹤0.01% 8531

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jane Street's VYGR Position: Q1 2026 in Review

Jane Street reduced its Voyager Therapeutics (VYGR) stake by 35% in Q1 2026, selling an estimated $204K and leaving 97,963 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #8693.

Jane Street first reported a position in VYGR in Q3 2019 and has held it in 17 quarters since. The position peaked at $1.52M in Q2 2024. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Jane Street held 97,963 shares of Voyager Therapeutics worth $378K as of Q1 2026.
  • Jane Street sold 51,784 Voyager Therapeutics shares in Q1 2026, an estimated $204K.
  • Voyager Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8693 holding.
  • Jane Street first reported a position in Voyager Therapeutics in Q3 2019 and has held it in 17 quarters since.
  • Jane Street's Voyager Therapeutics position peaked at $1.52M in Q2 2024.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.